Although the underlying mechanism remain unclear, somatic mutation and overexpression of ULK1/2 has been observed in several solid tumors such as colon cancer, hepatocellular carcinoma (HCC) and breast cancer 36-38. Here, ULK1 is linked to hepatocellular carcinoma.